Exploring Perceptual Learning in Blurred Gabor Discrimination for Low-Myopic Children
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jul 30, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special type of visual training can help improve distance vision in children aged 6 to 10 who have mild nearsightedness (also called low myopia). The training uses blurry patterns called "Gabor stimuli" on a digital system to help the brain learn to see more clearly without glasses. Children who join the study will be randomly placed into two groups: one group will do this vision training for about three months, while the other group will not. The researchers will also check if the training helps with other aspects of vision, like how well children see contrast, read Chinese characters, and how their eyes move.
To take part, children must be between 6 and 10 years old, have mild nearsightedness (a specific range of prescription), and have normal vision when wearing glasses. They should not be using any typical myopia treatments like special eye drops or contact lenses. Children with other eye problems, like crossed eyes or eye diseases, cannot join. If eligible, families can expect their child to participate in vision tests and the training sessions over a few months. This study is not yet open for enrollment, but it aims to find new ways to help children’s eyesight improve through brain training, not just glasses or medicine.
Gender
ALL
Eligibility criteria
- • Experimental and Control Group
- Inclusion Criteria:
- • 1. Children aged between 6 to 10 years.
- • 2. Best corrected distance visual acuity of 6/6 or 0.00 logMAR.
- • 3. Diagnosed with low myopia after a comprehensive ophthalmologic examination, with a spherical equivalent refractive error ranging from -0.50 to -1.25 diopters, including up to -0.75 diopters of astigmatism.
- 4. Not currently undergoing any of the four standard myopia control treatments for children:
- • 1. Atropine (mydriatic agent)
- • 2. Orthokeratology
- • 3. Peripheral defocus soft contact lenses
- • 4. Peripheral defocus spectacle lenses (frame glasses)
- • 5. Willing and able to provide informed consent, and able to comply with study procedures and assessments.
- Exclusion Criteria:
- Participants will be excluded if they have any of the following ophthalmologic conditions:
- • 1. Strabismus
- • 2. Binocular vision problems
- • 3. Ocular diseases
- • 4. History of ocular surgery (excluding refractive surgery)
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported